TB-500 Fragment 17-23: What It Is, How It Works, and Why It Matters

TB-500 Fragment 17-23: The Science Behind the Peptide

TB-500's full scientific name is thymosin beta-4 fragment 17-23, with the amino acid sequence Ac-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ). This specific sequence — just 7 amino acids out of the full 43-amino acid thymosin beta-4 protein — is responsible for the majority of TB4's tissue-repair activity.

---

What Does "Fragment 17-23" Mean?

Thymosin beta-4 (TB4) is a 43-amino acid protein. Scientists identified early on that not all 43 amino acids were equally important — some regions drove specific biological activities while others were structural.

Fragment 17-23 refers to amino acids 17 through 23 of the full TB4 sequence. This region contains the LKKTET motif, which is responsible for binding to actin — the protein that controls cell shape, movement, and division.

By isolating and synthesizing just this fragment, researchers created a smaller, more bioavailable molecule that retains the actin-binding properties of the full protein.

---

How Fragment 17-23 Works: Actin Upregulation

The core mechanism of TB-500 / fragment 17-23 is actin upregulation and sequestration.

Actin exists in two forms in cells:

G-actin (globular) — the free, inactive form

F-actin (filamentous) — the active form that drives cell structure and movement

TB-500 binds to G-actin and promotes its polymerization into F-actin. This has several downstream effects:

1. Cell migration — cells move more efficiently to injury sites
2. Angiogenesis — new blood vessel formation accelerates
3. Wound healing — keratinocytes and fibroblasts migrate faster to repair tissue
4. Inflammation reduction — actin dynamics play a role in modulating inflammatory signaling

---

TB-500 Fragment vs Full Thymosin Beta-4

| Property | Fragment 17-23 (TB-500) | Full TB4 |
|----------|------------------------|----------|
| Size | ~500 Da | ~4,921 Da |
| Amino acids | 7 | 43 |
| Bioavailability | High | Lower |
| Actin binding | ✓ (primary mechanism) | ✓ |
| Cardiac effects | Limited research | More data |
| Research availability | Widely available | Less common |
| Cost | Lower | Higher |

The fragment's smaller size is a significant advantage in research applications — it penetrates tissues more easily, is absorbed more rapidly, and reaches target sites more efficiently than the full protein.

---

Research Summary

Published research on thymosin beta-4 and its fragment includes:

Wound healing: Studies in the Annals of the New York Academy of Sciences demonstrated TB4 accelerates corneal and dermal wound healing in animal models

Cardiac protection: TB4 has been shown to reduce cardiomyocyte apoptosis after ischemic injury in rodent studies

Tendon repair: Animal studies show accelerated tendon healing with reduced scarring

Muscle repair: Promotes satellite cell activation and muscle fiber regeneration

Most mechanistic research uses the full TB4 protein, but the community has largely validated that TB-500 fragment 17-23 reproduces the repair-focused effects.

---

Frequently Asked Questions

Is TB-500 the same as fragment 17-23?
Yes. TB-500 is the commercial name for the synthetic peptide corresponding to thymosin beta-4 fragment 17-23 (Ac-LKKTETQ).

Is TB4-Frag 500 the same as TB-500?
Yes. "TB4 Frag 500" is another commercial naming convention for the same peptide. Always verify the amino acid sequence when purchasing for research.

Is thymosin beta-4 (TB4) the same as TB-500?
No. TB4 is the full 43-amino acid protein. TB-500 is specifically the active fragment (amino acids 17-23). TB-500 is derived from TB4 but is not identical to it.

---

TB-500 vs TB4 Fragment: Full Comparison

TB-500 vs BPC-157: Which Healing Peptide?

TB-500 Dosage Protocol Guide

What Is TB-500? Complete Guide

---

This content is for research and informational purposes only. TB-500 is not FDA-approved for human use.